Sativus Tech CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
Sativus Tech Corp.'s Q2 2026 Form 10-Q highlights significant financial challenges, including a substantial accumulated deficit and negative operating cash flow, raising serious concerns about its ability to continue as a going concern.
OTC.Pink
Sativus Tech Corp. reports continued operational losses and a significant accumulated deficit in its Q1 2026 10-Q filing, raising going concern doubts.
OTC.Pink
Sativus Tech Corp. reported a net loss of $266 thousand for Q3 2025 and $599 thousand for the nine months ended September 30, 2025, with auditors raising substantial doubt about its ability to continue as a going concern.
OTC.Pink
Sativus Tech Corp. reported a significantly reduced net loss for the second quarter of 2025, driven by improved financial expenses, but continues to face substantial doubt about its ability to continue as a going concern.
OTC.Pink
Sativus Tech Corp.'s Q1 2025 report reveals a net loss and continued concerns about the company's ability to meet its financial obligations.
OTC.Pink
Sativus Tech Corp.'s Q3 2024 results show a net profit of $2.07 million, but the company continues to face significant financial challenges and going concern uncertainty.
OTC.Pink
Sativus Tech Corp. reported a net loss of $2.8 million for the second quarter of 2024, primarily due to financial expenses related to convertible loans, as the company continues to develop its saffron growing technology.
OTC.Pink
Sativus Tech Corp.'s Q1 2024 results show a net income attributable to equity holders of $70,000, a significant improvement from a $186,000 loss in the same period last year, despite ongoing concerns about the company's ability to continue as a going concern.